B. Schulte

Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients with Inflammatory Bowel Diseases.

J. Raes, S. Szymczak, S. Schreiber, 2019, Gastroenterology.

Vedolizumab is associated with changes in innate rather than adaptive immunity in patients with inflammatory bowel disease

P. Rosenstiel, A. Franke, S. Zeissig, 2018, Gut.

Case Report: Arterial Wall Inflammation in Atherosclerotic Cardiovascular Disease is Reduced by Olamkicept (sgp130Fc)

P. Rosenstiel, M. Laudes, S. Rose-John, 2022, Frontiers in Pharmacology.

Autoantibodies to the islet antigen ICA 69 occur in IDDM and in rheumatoid arthritis

S. Martin, H. Kolb, F. Gries, 1995, Diabetologia.

Longitudinal multi-omics analysis identifies early blood-based predictors of anti-TNF therapy response in inflammatory bowel disease

Kenneth G. C. Smith, T. Spector, J. Raes, 2022, Genome Medicine.

Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases.

Michael Krawczak, Philip Rosenstiel, Silke Szymczak, 2017, Gastroenterology.

Soluble forms of intercellular adhesion molecule-1 inhibit insulitis and onset of autoimmune diabetes

S. Martin, H. Kolb, B. Schulte, 1998, Diabetologia.

Dominant role of intercellular adhesion molecule-1 in the pathogenesis of autoimmune diabetes in non-obese diabetic mice.

S. Martin, H. Kolb, B. Schulte, 2001, Journal of autoimmunity.

Development of Low-Dose Streptozotocin-Induced Diabetes in ICAM-1-Deficient Mice

B. Schulte, E. Heidenthal, A. Vinke, 1999, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.